Navigation Links
Namocell, Takara Bio USA and HepaTx collaborate on single cell genomics analysis for cell therapy to treat late-stage liver diseases
Date:2/21/2020

Namocell Inc., a leading provider of single cell sorting and dispensing platforms, announced today that it has entered into a collaboration with Takara Bio and HepaTx to use Namocell’s Single Cell Dispensers to perform single cell isolation on HepaTx’s unique hepatocyte-like cells (iHeps) developed from adipose tissue-derived stromal cells (ASCs), and characterize them by single cell RNA-seq (scRNA-seq) using Takara Bio’s SMART-seq® technology.

“We are excited to collaborate with Takara and HepaTx to leverage our unique single cell sorting and dispensing platform to support HepaTx’s innovative stem cell- based cell therapy that could revolutionize the treatment of late-stage liver diseases by replacing liver transplants. Namocell’s fast and gentle sorting and dispensing technology is enabling superior cell isolation for single cell analysis,” said Dr. Junyu Lin, CEO of Namocell.

“We are excited to be working with Namocell and HepaTx and contribute to the development of an innovative clinical solution. Leveraging our SMART-seq technology with Namocell’s single cell dispenser is an ideal match for performing plate based single cell RNA-seq enabling researchers to perform full length sequence analysis on single cells providing a deeper view into gene expression and cellular differentiation,” said Dr. Suvarna Gandlur, Associate Director of Next Generation Sequencing at Takara Bio USA.

“Namocell’s and Takara’s single cell technologies will help us advance our cell therapy platform to the clinic more quickly by enabling a deep molecular view of our development product. This will help us reach our goal of providing a scalable solution that can address clear clinical needs and provide better alternatives to liver transplants for patients,” said Dr. Eric Schuur, CEO of HepaTx.

About Namocell

Namocell provides innovative single cell sorting and dispensing platforms to empower single cell research and therapeutics development. Namocell’s single cell dispensers are the fastest and easiest way to identify and isolate single cells, and enable users to accomplish single cell sorting and dispensing in one step in a way that is gentle to live cells. We serve researchers and scientists in a wide range of applications, including single cell genomics, cell line development, CRISPR, cell therapy, stem cell, monoclonal antibody development, rare cell isolation, and synthetic biology. Learn more at http://www.namocell.com.

About HepaTx

HepaTx is a regenerative medicine company developing new types of stem cell-based treatments for patients with late stage liver disease, a highly underserved and cost intensive market. HepaTx’s proprietary process, licensed from Stanford and well protected by licensed IP, differentiates adipose stromal cells obtained from discarded lipoaspirate into functional hepatocytes. These hepatocytes are directly infused into the liver where they regenerate liver function. To learn more, visit our website, Hepatx.com and follow us on Twitter, @hepatx.

About Takara Bio USA

Takara Bio USA, Inc. (TBUSA; formerly Clontech Laboratories, Inc.) is a wholly owned subsidiary of Takara Bio Inc. that manufactures and distributes kits, reagents, and instruments for life science applications, including NGS, PCR, gene delivery, genome editing, stem cell research, nucleic acid and protein purification, and automated sample preparation.

Read the full story at https://www.prweb.com/releases/namocell_takara_bio_usa_and_hepatx_collaborate_on_single_cell_genomics_analysis_for_cell_therapy_to_treat_late_stage_liver_diseases/prweb16923622.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. EconoFact Collaborates with Macmillan Learning to Enhance Digital Learning Materials for Economics Courses
2. Abveris and Geneious Biologics Collaborate to Advance Antibody NGS Data Analysis
3. Abcam Collaborates with Visikol to Develop New Tools for Improved Tissue Clearing and 3D Imaging
4. Omixon & PIRCHE® collaborate on Epitope Determination with NGS
5. Syngrafii & San Antonio Credit Union (SACU) Collaborate on Remote Document Execution
6. Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices
7. NSF and NIH collaborate to accelerate advance of biomedical innovations into the marketplace
8. NIH and NSF collaborate to accelerate biomedical research innovations into the marketplace
9. EU initiative Climate-KIC and regional innovation network ERRIN to collaborate
10. UTMB collaborates on program targeting potential bioterrorist pathogens Ebola and Marburg
11. Researchers collaborate to reduce effects of the aging eye
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2020)... ... March 05, 2020 , ... In September 2016, stem cell ... Test™ is the first, and still only, available technology that provides the cell-specific ... provide information about the number and quality of therapeutic tissue stem cells are ...
(Date:3/4/2020)... (PRWEB) , ... March 04, 2020 , ... ... DNA-based products and services, announced it has been nominated as a finalist in ... (ViE) Awards. This nomination comes as VGXI expedites manufacturing of a DNA vaccine ...
(Date:3/3/2020)... ... March 03, 2020 , ... Board-certified oral and maxillofacial surgeon, ... over 16 years of training and experience, Dr. Noffze can successfully extract problem and ... as soon as possible is beneficial to the oral and overall health of most ...
Breaking Biology News(10 mins):
(Date:3/3/2020)... (PRWEB) , ... March 03, 2020 , ... ... was invited to present the latest breast implant technology at the IMCAS Innovation ... and new innovations in the dermatology, plastic surgery, and aesthetic science industries that ...
(Date:2/21/2020)... TORONTO (PRWEB) , ... February ... ... demonstrates an exquisite capability to perform complex, efficient and elegant chemistry. Humans ... and algorithms to our own goals. , Through rapidly evolving technologies and ...
(Date:2/19/2020)... , ... February 18, 2020 , ... ... devices, today announced the launch of a new and unified global brand identity, ... the industry’s most complex engineering challenges, as well as an enthusiasm for designing ...
(Date:2/10/2020)... ... February 10, 2020 , ... R3 Medical Training announced it ... 13-14th, 2020 in Las Vegas. The course is hands on involving real patients and ... past few years, the Comprehensive Stem Cell Training Course has received rave reviews from ...
Breaking Biology Technology: